Heat Biologics, Inc.
COMBINATION CELL-BASED THERAPIES

Last updated:

Abstract:

The present disclosure provides methods of treatment with cells having a vaccine (e.g., gp96-Ig) and cells having a T-cell co-stimulatory molecule.

Status:
Application
Type:

Utility

Filling date:

1 Oct 2019

Issue date:

11 Nov 2021